Non-Invasive Blood Pressure Monitors Market Size & Share, by Device Type (Automated BP Monitors, Ambulatory BP Monitors, Sphygmomanometers, BP Transducers); Technology, Accessory; End user - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2025-2037

  • Report ID: 7317
  • Published Date: Mar 10, 2025
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Non-Invasive Blood Pressure Monitors Market size was over USD 30.6 billion in 2024 and is estimated to reach USD 72 billion by the end of 2037, expanding at a CAGR of 7.4% during the forecast timeline, i.e., 2025-2037. In 2025, the industry size of non-invasive blood pressure monitors is evaluated at USD 32.8 billion.

Non-invasive blood pressure monitors are suitable for monitoring blood pressure without invasive procedures which resulted in achieving popularity in both household and healthcare environments. According to the 2025 WHO report, high blood pressure has resulted in 7.5 million deaths, accounting for 12.8% globally which is highly driving the demand for the non-invasive blood pressure monitors market. As per a report published by Research Nester, the global blood pressure monitors market was worth USD 1.2 billion in 2024, which is expected to grow at 11.8% by 2037. Therefore, this readily contributes to the rising adoption of non-invasive blood pressure devices owing to wireless technology and smartphone applications.

Furthermore, the implementation of automated upper arm cuff BP-measuring devices for clinic and home blood pressure (BP) monitoring also caters to the upliftment of the non-invasive blood pressure monitors market. In this regard, a comparative analysis was initiated regarding the payer’s pricing of nonvalidated and validated blood pressure measuring devices sold across countries on online platforms, as stated in the May 2023 NLM article. The study revealed that the cost of nonvalidated upper arm devices was USD 35.2 in comparison to validated devices with a median of USD 32.0. Likewise, the cost of nonvalidated wrist cuff devices was USD 23.7, more cost-effective than validated devices wrist devices with a median price of USD 25.7.

Upper Arm Devices vs Wrist Cuff Devices Estimated Price Based on Countries

Countries

Upper Arm Devices

Wrist Cuff Devices

Nonvalidated

Validated

Nonvalidated

Validated

Australia

USD 45.0

USD 106.0

USD 43.0

USD 45.0

France

USD 32.0

USD 76.0

USD 25.0

USD 62.0

India

USD 20.0

USD 74.0

USD 19.0

USD 55.0

Italy

USD 32.0

USD 76.0

USD 28.0

USD 58.0

Mexico

USD 48.0

USD 77.0

USD 34.0

USD 75.0

Spain

USD 32.0

USD 64.0

USD 25.0

USD 35.0

United Kingdom

USD 29.0

USD 47.0

USD 26.0

USD 46.0

Source: NLM May 2023


Non-Invasive Blood Pressure Monitors Market Size
Get more information on this report: Request Free Sample PDF

Non-Invasive Blood Pressure Monitors Sector: Growth Drivers and Challenges

Growth Drivers

  • Increased prevalence of hypertension: It is commonly known as elevated blood pressure which serves as a significant force driving the enlargement of the non-invasive blood pressure monitors market. According to the March 2023 WHO report, approximately 1.28 billion adults between the age of 30 years to 79 years are diagnosed with hypertension with two-thirds of the global population residing in low- and middle-income nations. Besides, 42% of the global adult population is treated with the use of blood pressure monitoring devices, and an estimated 1 in 5 adults, that is 21% have control of the condition with the implementation of these devices, thus driving market growth.
  • Implementation of telemedicine: The aspect of digitalization in the healthcare industry has resulted in the provision of remote medical services, which constitutes a positive impact on the non-invasive blood pressure monitors market. As per the October 2022 CDC report, 42.0% of women are more likely to adopt telehealth services in comparison to 31.7% of men. Besides, adults utilizing this mode of medication have increased from 29.4% to 43.3% for the age group of 18 to 29 years. Thereby, all these evidences are effective enough to boost telemedicine which in turn is suitable to uplift the market globally.

Challenges

  • Inadequate accuracy: A notable hindrance to the non-invasive blood pressure monitors market is accurate concerns regarding the readings of the monitoring devices. Any eccentricities from precision can result in incorrect diagnoses, misguided treatment decisions, and destabilize confidence in the reliability of these devices. In addition, the dependability of blood pressure monitors is dominant, as patients and healthcare practitioners depend on their precision for crucial healthcare determinations. Therefore, any shortcomings in accuracy level may discourage both consumers and healthcare providers from approving these essential monitoring devices.
  • In-effective recommendations from health professionals: Poor communication and pieces of advice regarding the use of monitoring devices are a huge challenge for the non-invasive blood pressure monitors market to flourish. Severe misunderstandings lead to medical errors resulting in misdiagnosis and suboptimal treatments of blood pressure-based conditions. This further deteriorates the overall health situation of patients, which results in life-threatening conditions. Thereby, suitable recommendations as per available and well research medical guidelines is acceptable to combat these challenges.

Base Year

2024

Forecast Year

2025-2037

CAGR

7.4%

Base Year Market Size (2024)

USD 30.6 billion

Forecast Year Market Size (2037)

USD 72 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Non-Invasive Blood Pressure Monitors Segmentation

Device Type (Automated BP Monitors, Ambulatory BP Monitors, Sphygmomanometers, BP Transducers)

Automated BP monitors segment is poised to capture over 71.6% non-invasive blood pressure monitors market share by 2037. These types of monitors ensure easy-to-use, fully automated readings, making them popular for both healthcare professionals and individuals at home. In January 2022, Aktiia unveiled the world’s first automated 24/7 blood pressure monitor in the U.S. to deliver the next generation of clinical wearables, specially designed to address the requirements of both patients and physicians. Additionally, these devices diminish human errors and provide consistent as well as rapid results, thus resulting in the segment’s growth.

Technology (Digital, Aneroid, Wearable)

By 2037, digital segment is expected to capture over 49.5% non-invasive blood pressure monitors market share. Digital monitors can offer more accurate and appropriate blood pressure readings, making them preferred by healthcare professionals and users alike. Besides, 75% of healthcare facilities, especially in the U.S. utilize electronic health record systems to aid patients suffering from disorders, as stated in the February 2023 NLM article. Moreover, the provision of advanced features of digital monitors such as data analysis, compatibility with mobile apps, and memory storage enhance their efficacy, thus boosting the segment.

Our in-depth analysis of the global non-invasive blood pressure monitors market includes the following segments:

Device Type

  • Automated BP Monitors
  • Ambulatory BP Monitors
  • Sphygmomanometers
  • BP Transducers

Technology

  • Digital
  • Aneroid
  • Wearable

Accessory

  • Blood Pressure Cuffs
  • Manometers
  • Valves
  • Tubing
  • Bulb

End user

  • Hospitals
  • Clinics
  • Ambulatory Surgical Center
  • Home Care Setting
  • Others

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Non-Invasive Blood Pressure Monitors Industry - Regional Synopsis

North America Market Analysis

North America non-invasive blood pressure monitors market is expected to dominate revenue share of around 67.2% by the end of 2037. The substantial presence of the elderly population is positively driving the market demand and expansion. According to the January 2024 Population Reference Bureau report, there will be an increase in the population category from 58 million to 82 million, which is 47% by 2050. This further accounts for a rise in the total share of the regional population from 17% to 23%. Therefore, this denotes a surge in the demand for non-invasive blood pressure devices to aid this particular population from high blood pressure conditions.

The U.S. non-invasive blood pressure monitors market has been gaining traction due to the involvement of administrative bodies in the approval of devices based on guidelines. For instance, in November 2023, the U.S. FDA successfully issued emergency use authorizations (EUAs) for the accessibility of remote or wearable patient monitoring devices. The purpose was to ensure assistance in increasing the availability of monitoring and treatment of patients and to address the reduction of healthcare provider acquaintance with SARS-CoV-2 during the COVID-19 pandemic. Devices including remote patient QT interval monitor, nurse call system, and patient isolation transport unit (PITU) are a few approved devices by the FDA based on EUAs.

The non-invasive blood pressure monitors market in Canada is witnessing significant growth owing to the increased availability of blood pressure monitors. For instance, the University of Ottawa Heart Institute in its 2025 article stated the use of an ambulatory blood pressure monitor as a moveable blood pressure recording device, suitable for recording readings at definite times during 24 hours. The device comprises an arm cuff attached by a flexible rubber tube to a lightweight monitor, which is favorable for patients suffering from high blood pressure. This particular test is available with a charge of USD 100.0, making it cost-effective and an efficient test device in the country.

APAC Market Statistics

The non-invasive blood pressure monitors market in APAC is the fastest-growing region and is poised to witness lucrative growth during the forecast timeline. The region is subjected to an increased focus on technological innovations and preventive healthcare measures. These devices serve as a pivotal tool in the region for monitoring cardiovascular health. As per the August 2025 Launcet report, crude cardiovascular mortality is anticipated to increase by 91.2% by 2050 in the region despite a 23.0% decrease in the age-standardized cardiovascular mortality rate. Therefore, the demand for non-invasive blood procedure monitor devices is also expected to increase in the region, catering to the need to evaluate heart rates of the population.

The non-invasive blood pressure monitors market in India is expecting substantial growth since critically ill children suffer from seizures, resulting in the increased use of these devices. Regarding this, a clinical was conducted in the regional research institutes in June 2024, wherein 40 children with 1,072 paired blood pressure measurements were analyzed and the limited level of agreement between non-invasive blood pressure (NIBP) and invasive blood pressure (IBP) measurements was 95%, resulting in the probable overestimation or underestimation of blood pressure. However, NIMB functioned as a screening method for hemodynamically stable children and IBP for hemodynamically unstable children, thus amplifying the market development.

The non-invasive blood pressure monitors market in China is gaining exposure owing to the adoption of wearable non-invasive blood pressure measurement technology that has attracted much research attention. Based on this, a cross-sectional study was conducted by NLM in February 2025 regarding the characteristics of sleep-monitoring devices in the country. Approximately 203 sleep devices gathered from four major mobile shopping platforms were evaluated. Smart bracelets accounted for 82.6% of sleep monitoring devices catering to recording sleep quality and duration, physical activity blood oxygen saturation, and heart rate. Most of these devices are priced at 500 RMB (USD 68.8), thus suitable for market growth.

Non-Invasive Blood Pressure Monitors Market Share
Get more information on this report: Request Free Sample PDF

Companies Dominating the Non-Invasive Blood Pressure Monitors Landscape

    The global non-invasive blood pressure monitors market is perceiving strong competition as it is price-sensitive. Besides, organizations are implementing competitive strategies including mergers and acquisitions, planned alliances, collaborative agreements, and partnerships to withstand the competition. For instance, in November 2022, CardieX Limited acquired all the assets of Blumio, Inc. signifying the company’s sustained investment in cardiovascular health monitoring technologies. Blumio’s technology has the potential to significantly upsurge clinical performance for CardieX’s ecosystem of heart health monitoring solutions, thus a positive contribution toward market enhancement.

    Here's the list of some key players:

    • Omron Healthcare Welch Allyn, Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • A&D Medical Inc.
    • SunTech Medical, Inc.
    • American Diagnostics Corp.
    • Withings
    • Briggs Healthcare
    • GE Healthcare
    • Kaz Inc.
    • Microlife AG
    • Rossmax International Ltd.
    • GF Health Products Inc.
    • Spacelabs Healthcare Inc.
    • Philips Healthcare
    • Hill-Rom Services Inc.
    • Braun Healthcare
    • Contec
    • Biobeat
    • Dynocardia
    • Caretaker Medical
    • CardieX Limited

In the News

  • In December 2024, Dynocardia received a USD 1 million NSF grant to improve its exclusive computer vision-based motion-correction technology and enlarge the applications of its ViTrack continuous non-invasive blood pressure (cNIBP) monitor.
  • In April 2022, Caretaker Medical notified the FDA 510(k) Clearance for four latest continuous hemodynamic parameters, adding cardiac output, stroke volume, heart rate variability, and left ventricular ejection time to its VitalStream non-invasive patient monitoring platform.

Author Credits:   Radhika Pawar


  • Report ID: 7317
  • Published Date: Mar 10, 2025
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2024, the industry size of the non-invasive blood pressure monitors market was over USD 30.6 billion.

The market size for the non-invasive blood pressure monitors market is projected to reach USD 72 billion by the end of 2037 expanding at a CAGR of 7.4% during the forecast period i.e., between 2025-2037.

The major players in the market are Omron Healthcare Welch Allyn, Inc., A&D Medical Inc., SunTech Medical, Inc., American Diagnostics Corp., and others.

In terms of the device type segment, the automated BP monitors segment is anticipated to garner the largest market share of 71.6% by 2037 and display lucrative growth opportunities during 2025-2037.

The market in North America is projected to hold the largest market share of 67.2% by the end of 2037 and provide more business opportunities in the future.
footer-bottom-logos
GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

See our insights in action - schedule your demo now!

Live Sample Reading